Abstract. Osteoclasts, which are responsible for bone resorption, are rare cells with only 2-3 cells seen per 1 turn 3 of bone. However, the loss of function in osteoclasts, problems with their differentia tion and decrease in their number lead to bone osteosclerosis/osteopetrosis. On the other hand, an increase in their number or function induces bone osteoporosis, indicating that osteoclasts play a pivotal role in bone homeostasis. It has been demonstrated that bone destruction and hypercalcemia induced by metastatic tumors are carried out by osteoclasts activated by the tumor cells, and the inhi bition of osteoclast formation prevents the bone destruction and even bone metastasis. Abnormal osteoclast function is closely related to various diseases. Furthermore, osteoclasts are indispensable in forming bone marrow to produce blood cells, and the absence of osteoclasts causes osteopetrosis, resulting in extramedullary hematopoiesis. Although the physiological roles of osteoclasts are well described, the mechanisms of their differentiation remain to be elucidated. Recently, RANK (receptor activator of nuclear factor kappaB) and its ligand (RANKL) have been identified and their essential roles in osteoclastogenesis have been demonstrated, which has provided new insights into the osteo clast differentiation pathway. We have established an in vitro osteoclast culture system by isolating osteoclast precursor cells and culturing them in the presence of macrophage colony stimulating factor 
In postnatal life, bone is continuously remodeled by osteoblasts and osteoclasts, which synthesize bone matrix and resorb bone, respectively. Osteoblasts are derived from mesenchymal stem cells with a potential to differentiate to chondrocytes, adipocytes and stromal cells (Fig. 1) .1 On the other hand, osteoclasts are derived from hematopoietic stem cells (Fig. 1 ). These two kinds of cell, though of different origins, cooperate with each other to maintain homeostasis of bony tissue. Any imbalance between bone formation by osteoblasts and bone resorption by osteoclasts causes bone abnor malities including osteopetrosis (due to a defect in osteoclastogenesis or the absence of functional osteo clasts), osteosclerosis (due to increased bone forma tion) and osteoporosis (due to increased bone resorp tion or a relative decrease in bone formation compared with bone resorption). Therefore, osteoclasts are indis pensable to maintain bone homeostasis.
Hematopoiesis shifts to the bone marrow con comitantly with the formation of the bone marrow cavity from the fetal liver. The bone is formed through chondrocytes or the mesenchymal membrane. Pro liferating chondrocytes prevent the vascular invasion mediated by angiogenesis-inhibitory factors such as chondromodulin in the early embryonic stage.2 In the later stage, hypertrophic chondrocytes differentiating from chondrocytes in the center of the bone induce vascular invasion, mediated by angiogenic factors such as vascular endothelial growth factors (VEGFs) (Fig.  2) . The induced vascular system establishes the blood supply to, and circulation in the bony structures, and it supplies osteoclasts, which resorb the bone to create the bone marrow cavity filled with hypertrophic and mineralized chondrocytes. Hematopoietic stem cells (HSCs) lodge in the stromal cells of the newly formed bone marrow, whereafter medullary hematopoiesis begins. In the absence of osteoclasts, the bone marrow cavity is not formed and extramedullary hematopoiesis takes place in the spleen, liver and kidney.
Characterization of Osteoclasts
The definition of osteoclasts is "bone resorbing cells". Osteoclast differentiation has various character istic features, such as multinucleation induced by the cell fusion of mononuclear osteoclasts to cover a larger area, synthesis of the vacuolar proton pump and acid to dissolve the bone mineral, formation of ruffled borders to secret protons and acid, and formation of a sealing zone to prevent proton and acid leakage.
Mononuclear osteoclasts tightly adhere to bone, and fuse with each other to form multinuclear osteoclasts. The fused cells are re-organized, polarized and con struct osteoclast-specific structures. Transcytosis devel ops from the basal to the apical side of osteoclasts to enable the discharge of dissolved bone debris. RANKL induce osteoclast differentiation in a stroma cell-free culture in vitro. Bone marrow mononuclear cells were subdivided into three fractions by cell sur face markers (c-Fms+RANK-, c-Fms+RANK+, c Fms-RANK+) (Fig. 4) . (Fig. 4) . The difference in multinuclear formation between c Fms+RANK-and c-Fms+RANK+ is caused by the cell density, and the difference of cell density results from the proliferating activity between these fractions.17 c Fms+RANK-fraction showed colony-forming activity in the presence of M-CSF alone or M-CSF and sRANKL, while c-Fms+RANK+ did not. Multinuclear osteoclasts were formed from c-Fms+RANK+ cells when ten times more cells were cultured suggesting adequate cell density is required to fuse and form mul tinuclear osteoclasts. 17 From the results above, c-Fms+RANK-cells have the highest multinuclear osteoclast formation activity, however, these cells do not express RANK. We have shown that M-CSF induced RANK expression in the c-Fms+RANK-cells first, and then RANKL induced the differentiation signal (Fig. 5) . 18 In the absence of RANKL, these cells differentiated into macrophages through a default pathway.
Anchorage-dependent Osteoclastogenesis
Osteoclast formation is restricted to the bone sur face, suggesting that bone provided a suitable environ ment for osteoclastogenesis. Although the expression of RANKL is relatively limited in osteoblasts , it is also expressed in other cells and tissues, such as T cells and spleen cells. We therefore studied the effect of adherent or non-adherent culture conditions on osteoclast pro liferation and differentiation. We prepared the adher- ent condition in plastic culture dishes with a liquid me dium to permit cell adhesion, whereas the non-adherent condition was prepared using a methylcellulose semi solid culture medium to inhibit cell adhesion to the substrate. Under adherent condition, osteoclastogen esis with multinucleation was induced.17 However, under non-adherent condition, osteoclast formation was reduced to approximately 30% compared with the ad herent condition and no multinuclear osteoclasts were formed.17 The reduced differentiation activity to osteo clasts seen under non-adherent condition was recovered, when the cells were transferred to the adherent condi tion, indicating that osteoclasts progenitors can differ entiate into osteoclast through adhesion to the matrix. Alternatively, osteoclastogenesis was stimulated by oligomerized RANKL under non-adherent conditions. RANKL is a member of the TNFa superfamily known to act as a trimer form. Actually, the trimerized RANKL called leucin-zipper RANKL (LZ-RANKL) effectively induced osteoclastogenesis compared with the monomer form even under non-adherent condi tions. Thus, adhesion might be required to transduce the efficient RANK signaling for osteoclastogenesis. On the other hand, multinucleation was not fully induced by LZ-RANKL. This suggests that the polarity of cell adhesion is important for cell fusion. Anchorage dependent osteoclastogenesis might be involved in the prevention of ectopic osteoclast formation.
Dendritic Cell Differentiation from Osteoclast Precursor Cells
Although the osteoclast differentiation is reduced under non-adherent conditions, it is not completely inhibited, suggesting that some other osteoclastogenesis inhibitory system might be involved in tissues other than bone. Lymphoid tissues including the spleen and lymph nodes express the molecules for osteoclasto genesis in vitro such as M-CSF and RANKL. However, no osteoclast formation is induced in these tissues.
We analyzed the effect of GM-CSF expressed in lymphoid tissues on osteoclast differentiation.5 Osteo clastogenesis was completely inhibited by GM-CSF at an early stage of differentiation in a dose-dependent manner, and cells were committed to a dendritc cell lineage, judging from the fact that CD11c and DEC205 were expressed by GM-CSF. Therefore, osteoclast pre cursor cells have the potency to differentiate into osteoclasts, macrophages and dendritic cells (Fig . 5) In adult T-cell leukemia (ATL) patients, hyper calcemia is induced concomitantly with an increased number of osteoclasts and accelerated bone resorp tion. Several cytokines, such as PTHrP, IL-1 and TGF beta are implicated in ATL associated hypercalcemia. These cytokines indirectly induce osteoclastogenesis via stroma cells. However, from the aspect that increased osteoclastogenesis is mainly observed in the local area of tumor invasion, we speculated that ATL cells might express a membrane associated protein and directly induce osteoclastogenesis. Among the molecules, we studied the expression of RANKL. ATL cells from patients with hypercalcemia induced osteoclast differ entiation, whereas ATL cells from non-hypercalcemic patients did not.20 ATL cells from hypercalcemic patients expressed high levels of RANKL, whereas cells from normocalcemic patients did not. A soluble recep tor for RANKL inhibited osteoclastogenesis, indicat ing that RANKL expressed by ATL directly induced osteoclast differentiation. As observed in ATL, other bone metastatic tumors such as breast cancer and multiple myeloma cells express RANKL, and induce osteoclastogenesis. These lines of evidence indicate that pathological bone fractures and hypercalcemia caused by bone metastasis are induced by osteoclasts activated by tumor cells. These fractures sometime cause paraly sis, and the presence of hypercalcemia is associated with a poor prognosis. The regulation of osteoclasto genesis in the metastatic bone tumor is an important problem when trying to maintain the patient ' 
